Exact Sciences Corp. (Nasdaq: EXAS) today announced that its board of
directors has appointed Kevin T. Conroy, the company’s president and
chief executive, as chairman of the board. David A. Thompson, a director
of the company since 2010, will serve as lead independent director.
Earlier in the week, James P. Connelly, the company’s chairman since
2010, resigned from the board for personal reasons.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the
early detection and prevention of colorectal cancer. The company has
exclusive intellectual property protecting its non-invasive, molecular
screening technology for the detection of colorectal cancer. Stool-based
DNA technology is included in the colorectal cancer screening guidelines
of the American Cancer Society and the U.S. Multi-Society Task Force on
Colorectal Cancer. For more information, please visit the company’s
website at www.exactsciences.com.
Certain statements made in this news release contain forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities and Exchange Act of
1934, as amended, that are intended to be covered by the “safe harbor”
created by those sections. Forward-looking statements, which are based
on certain assumptions and describe our future plans, strategies and
expectations, can generally be identified by the use of forward-looking
terms such as “believe,” “expect,” “may,” “will,” “should,” “could,”
“seek,” “intend,” “plan,” “estimate,” “anticipate” or other comparable
terms. Forward-looking statements in this news release may address the
following subjects among others: statements regarding the sufficiency of
our capital resources, expected operating losses, anticipated results
and timing of our pivotal clinical trial, expectations concerning our
ability to secure FDA approval of our Cologuard test, expected license
fee revenues, expected research and development expenses, expected
general and administrative expenses and our expectations concerning our
business strategy. Forward-looking statements involve inherent risks and
uncertainties which could cause actual results to differ materially from
those in the forward-looking statements, as a result of various factors
including those risks and uncertainties described in the Risk Factors
and in Management’s Discussion and Analysis of Financial Condition and
Results of Operations sections of our most recently filed Annual Report
on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q.
We urge you to consider those risks and uncertainties in evaluating our
forward-looking statements. We caution readers not to place undue
reliance upon any such forward-looking statements, which speak only as
of the date made. Except as otherwise required by the federal securities
laws, we disclaim any obligation or undertaking to publicly release any
updates or revisions to any forward-looking statement contained herein
(or elsewhere) to reflect any change in our expectations with regard
thereto or any change in events, conditions or circumstances on which
any such statement is based.
Copyright Business Wire 2014